Technical Analysis for NVIV - InVivo Therapeutics Holdings Corp.

Grade Last Price % Change Price Change
grade F 1.13 0.89% 0.01
NVIV closed up 0.89 percent on Friday, May 24, 2019, on 6 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Earnings due: May 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical NVIV trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Low Weakness 0.89%
Wide Bands Range Expansion 0.89%
Oversold Stochastic Weakness 0.89%
20 DMA Resistance Bearish 4.63%
New 52 Week Closing Low Bearish 4.63%

Older signals for NVIV ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Invivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, focuses on developing and commercializing technologies for the treatment of spinal cord injury (SCI). The company is developing a Neuro-Spinal Scaffold, an investigational bioresorbable polymer scaffold for the implantation at the site of injury within a spinal cord contusion; and biocompatible Neuro-Spinal Scaffold Plus Stem Cells to treat chronic SCI. Its proprietary technologies incorporate intellectual property licensed under exclusive, worldwide license from Boston Children's Hospital and the Massachusetts Institute of Technology, as well as intellectual property that has been developed internally in collaboration with advisors and partners. The company was founded in 2005 and is based in Cambridge, Massachusetts.
Biotechnology Organ Systems Stem Cells Nervous System Injury Biomaterials Injuries Medical Emergencies Spinal Cord Injury Neurotrauma
Is NVIV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 7.6
52 Week Low 1.06
Average Volume 64,776
200-Day Moving Average 1.7096
50-Day Moving Average 1.4299
20-Day Moving Average 1.2385
10-Day Moving Average 1.159
Average True Range 0.1083
ADX 32.58
+DI 12.3525
-DI 18.6936
Chandelier Exit (Long, 3 ATRs ) 1.1751
Chandelier Exit (Short, 3 ATRs ) 1.3849
Upper Bollinger Band 1.4299
Lower Bollinger Band 1.0471
Percent B (%b) 0.22
BandWidth 30.908357
MACD Line -0.0911
MACD Signal Line -0.0862
MACD Histogram -0.0048
Fundamentals Value
Market Cap 36.37 Million
Num Shares 32.2 Million
EPS -0.76
Price-to-Earnings (P/E) Ratio -1.49
Price-to-Sales 0.00
Price-to-Book 2.29
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.19
Resistance 3 (R3) 1.19 1.16 1.18
Resistance 2 (R2) 1.16 1.15 1.17 1.18
Resistance 1 (R1) 1.15 1.14 1.16 1.15 1.17
Pivot Point 1.12 1.12 1.13 1.13 1.12
Support 1 (S1) 1.11 1.11 1.12 1.11 1.09
Support 2 (S2) 1.08 1.10 1.09 1.08
Support 3 (S3) 1.07 1.08 1.08
Support 4 (S4) 1.07